Rebecca Goldstein Rebecca Goldstein

Rebecca is a PhD-trained research scientist with over 15 years of strategy, communications, and consulting experience in 30 different cancer types. She has a passion for making complex cancer biology relatable and strategically relevant, with the goal of de-risking fast-paced programs so the best innovations become cures. Her specialties include positioning, strategy, and practical implementation for innovations in cancer. Rebecca can be reached at rebecca.goldstein@envisionpharma.com

Oncology Commercial Strategy: Broader Is Better

Now more than ever, oncology innovators need to ground early commercial decision making in ...